At what enterprise value was DOMUSVI acquired in 2021?

During the acquisition of DOMUSVI by ICG / MANAGEMENT & PRIVATE INVESTORS in 2021, the transaction's Enterprise Value is estimated to be in the range of 3b - 100b EUR.

What was the EV/EBITDA of DOMUSVI when it was acquired by ICG / MANAGEMENT & PRIVATE INVESTORS?

The estimated EV/EBITDA multiple for DOMUSVI is in the range of 15x - 25x.

When was DOMUSVI acquired by ICG / MANAGEMENT & PRIVATE INVESTORS?

DOMUSVI was acquired by ICG / MANAGEMENT & PRIVATE INVESTORS in 2021.

What was the revenue of DOMUSVI at the time of the deal?

The revenue of DOMUSVI at the time of the deal is estimated to be in the range of 1b - 3b EUR.

What was the EBITDA of DOMUSVI during the acquisition?

DOMUSVI's EBITDA is estimated to be in the range of 250M - 500M EUR.

How is the data for the DOMUSVI acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the DOMUSVI deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.agefi.fr/private-equity/actualites/le-gestionnaire-dehpad-domusvi-signe-un-jumbo-lbo

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaDOMUSVI

04/2021

DOMUSVI acquired by ICG & MANAGEMENT & PRIVATE INVESTORS

FRANCE Health Providers / Healthcare Facilities / Nursing Homes EV 3b - 100b EUR

Context

DomusVi completed a major capital reorganization, described as a "jumbo-LBO". This transaction allowed founder Yves Journel to increase his ownership from 30% to 49%, while ICG remains a key controlling partner. The group's management team also participated in the round, investing approximately €50 million for a 2% stake. The deal was financed through a robust structure including €1.6 billion in portable senior debt (representing 6.3x EBITDA) and a €400 million PIK (Payment-in-Kind) line provided by ICG. The strategic rationale is to fund a "European conquest" phase, aiming to double the group's revenue to €3.4 billion by 2025. This growth will be driven by massive external acquisitions in Germany, Italy, Belgium, and Portugal, further consolidating DomusVi's position as a dominant European healthcare provider.

Previously, the company had already undergone several LBOs, notably led by Pai Partners in 2014 and Icg / Management & Private Investors in 2017. This succession of buyouts, combined with an active build-up strategy, highlights the strong attractiveness of the company's business model.

DOMUSVI, which reported an EBITDA margin of in 2020, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

DomusVi stands as a leading international provider of high-quality elderly care and specialized services. The group operates an extensive cross-border network across Europe and Latin America, encompassing medicalized nursing homes, mental health facilities, and home care agencies. The entity actively executes a targeted buy-and-build strategy aimed at securing and strengthening its premier position within its domestic market. DomusVi’s value proposition is built upon a multi-disciplinary approach to dependency and senior care, seamlessly integrating medicalized residential care, specialized disability centers, and home assistance solutions to deliver a comprehensive support ecosystem for seniors and their families.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Other operations with DOMUSVI

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
03/2019	DOMUSVI	RESIDALYA	FRANCE	Nursing Homes
06/2017	ICG / MANAGEMENT & PRIVATE INVESTORS	DOMUSVI	FRANCE	Nursing Homes
10/2016	DOMUSVI	SARQUAVITAE	SPAIN	Nursing Homes
06/2014	PAI PARTNERS	DOMUSVI	FRANCE	Nursing Homes

REFERENCES

Valuation range: EV 3b - 100b EUR

Revenue range: 1b - 3b EUR

EBITDA range: 250M - 500M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of DOMUSVI by ICG / MANAGEMENT & PRIVATE INVESTORS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: icg